Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lunan Hope Pharmaceutical
Shandong, Chinalunan.com.cn ↗
- Ownership
- Private
- Employees
- ~9000
- Development stage
- Commercial
01
Overview
Lunan Hope Pharmaceutical, as part of Lunan Pharmaceutical Group, has multiple commercially approved drugs in China across small molecules, biosimilars, traditional Chinese medicine, and biologics. Select pipeline programs include novel bispecific antibodies (e.g., LNF1904) in Phase 1 for lymphoma and co-development of antibody-drug conjugates targeting oncology. Many products are approved and marketed in China and some have global filings.
- Therapeutic areas
- PsychiatryImmunologyGastroenterologyPulmonologyInfectious DiseasesOncologyCardiovascularHematologyEndocrinology
- Modalities
- Small moleculeMonoclonal antibodyBispecific T-cell Engager (BiTE)Herbal medicineBiosimilar
- Industry
- Pharma
02
Partnerships
Adcoris Biopharma (antibody-drug conjugate development)
Beyond the preview
Go deeper on Lunan Hope Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lunan Hope Pharmaceutical.